Drugs / budesonide/formoterol
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT03083067 | Mar 2017 → Mar 2022 | chronic obstructive pulmonary disease | Peking University First Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | budesonide/formoterol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03083067 ↗ |
| Route | Inhaled | “inhaled budesonide/formoterol（160ug/4.5ug）” NCT03083067 ↗ |